Ovarian Cancer is the 9th most common cancer in the world 1, and Europe has the highest rates of ovarian cancer in the world 2. Although the cancer antigen 125 (CA 125) assay has been used for more ...

Ovarian tumours and adnexal masses encompass a broad spectrum of pathologies, ranging from benign cysts to aggressive malignancies. Accurate and early diagnosis is critical due to the high mortality ...

Current clinical methods used to identify epithelial ovarian cancer are often too late – when the cancer is at an advanced stage, leaving the patient with limited therapeutic options. Diagnosis is ...

Please provide your email address to receive an email when new articles are posted on . Four adnexal mass classification algorithms successfully distinguished lesions when used by a novice operator. A ...

(HealthDay News) — For older women with small complex adnexal masses, the overall risk of malignancy is low, according to a study published in the December issue of the American Journal of Obstetrics ...

BURLINGTON, N.C.--(BUSINESS WIRE)-- Laboratory Corporation of America ® Holdings (LabCorp ®) (NYSE: LH) announced today the nationwide availability of a new FDA cleared risk stratification tool (ROMA ...

AUSTIN, Texas, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on the development of gynecologic disease ...

Three-dimensional power Doppler (3DPD) ultrasound has been used for assessing adnexal masses, and in this study, we aimed to perform a meta-analysis to evaluate its role in the differential diagnosis ...

Aspira Women’s Health Inc. AWH has taken a significant step forward in advancing the clinical treatment of adnexal masses by entering into a definitive agreement with Dorsata, a healthcare software ...